A Retrospective Analysis of Public Payer Health Care Patterns Associated with Duloxetine and Comparator Medications for Treating Depression and Diabetic Neuropathic Pain

About the Project

Examine public payer healthcare treatment patterns for Medicaid recipients. Determine the factors associated with the use of duloxetine versus comparator medications in the treatment of depressive disorders and the treatment of pain associated with DPN.

Click here to view Research Brief

Principal Investigator

Marion Becker, RN, PhD

Funding Agency

Eli Lilly and Company

Award Amount

$274,623

Dates

07/01/2005 - 12/31/2007